“Certara is transforming the way new medicines are discovered and developed helping bring treatments to patients faster and more efficiently,” said Daniel Corcoran, Senior Vice President and General Counsel. “We achieve this by delivering world-class biosimulation science and solutions to our clients, while also holding ourselves accountable to strong environmental, social, and governance practices. "
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.
Certara contact:
Sheila Rocchio
[email protected]
Media contact:
Alyssa Horowitz
[email protected]
